Dr. Husseini Manji’s affiliations are quite the laundry list: a professor of psychiatry at the University of Oxford with adjunct and visiting positions at Yale and Duke, as well as serving as co-chair of the UK government’s mental health mission. But it’s his earlier work as a pioneer in the development of rapid-acting antidepressants that concerns this interview, with Manji’s role in esketamine’s…
